Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

FDA 510(k)

Soberlink Cellular Device and Sober Sky Web Portal

Número K: K160613 · 2016-07-14

RequerenteSoberlink Healthcare, LLC
Data da decisão2016-07-14
Código do produtoDJZ
Comité consultivoTX
DecisãoSubstantially Equivalent

Resumo do dispositivo

Soberlink Cellular Device and Sober Sky Web Portal is the device name listed in this FDA 510(k) record. The listed applicant is Soberlink Healthcare, LLC. It received FDA 510(k) clearance on 2016-07-14 under 510(k) number K160613. The device is classified under product code DJZ. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the Soberlink Cellular Device and Sober Sky Web Portal?

Soberlink Cellular Device and Sober Sky Web Portal is a medical device that received FDA 510(k) clearance on 2016-07-14. The listed applicant is Soberlink Healthcare, LLC. The 510(k) number is K160613.

When did Soberlink Cellular Device and Sober Sky Web Portal receive FDA 510(k) clearance?

Soberlink Cellular Device and Sober Sky Web Portal received FDA 510(k) clearance on 2016-07-14, under 510(k) number K160613.

Who is the listed applicant for Soberlink Cellular Device and Sober Sky Web Portal?

The FDA 510(k) record lists Soberlink Healthcare, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Soberlink Cellular Device and Sober Sky Web Portal?

The FDA product code for Soberlink Cellular Device and Sober Sky Web Portal is DJZ.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.

↑